Please use this identifier to cite or link to this item:
|Title:||Human Embryonic Stem Cell Patents: A European Perspective|
|Abstract:||Although patents involving human embryonic stem cells have been granted in USA and some other countries, the situation in Europe has been complicated by ethical exclusion clauses in the European Patent Convention and the European Biotechnology Directive. These have resulted in protracted delays in the processing of embryonic stem cell patents by the European Patent Office. It is concluded that ethical exclusion from grant of patents may not be appropriate. It is also suggested that the desirability of granting broad patents that lay claim to a large body of future research should be discussed. This paper discusses aspects of the patenting of stem cell processes and products with particular emphasis on human embryonic stem cells.|
|Appears in Collections:||JIPR Vol.12(1) [January 2007]|
Files in This Item:
|JIPR 12(1) (2007) 30-37.pdf||125.97 kB||Adobe PDF||View/Open|
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.